The global Drug Eluting Stent market, valued at USD 7.80 billion in 2023, is projected to achieve a remarkable growth rate, reaching USD 14.98 billion by 2031, expanding at a CAGR of 8.5% during the forecast period from 2024 to 2031. This robust growth is driven by advancements in medical technology, increasing prevalence of cardiovascular diseases, and rising demand for minimally invasive...